STOCK TITAN

Ventas Stock Price, News & Analysis

VTR NYSE

Welcome to our dedicated page for Ventas news (Ticker: VTR), a resource for investors and traders seeking the latest updates and insights on Ventas stock.

Ventas, Inc. (VTR) is a leading healthcare real estate investment trust (REIT) specializing in senior housing communities, medical offices, and life science facilities. This page serves as the definitive source for official company announcements and market-moving developments.

Investors and industry professionals will find timely updates including quarterly earnings reports, property portfolio expansions, and strategic partnerships. Our curated news collection provides essential insights into operational milestones across Ventas' diversified healthcare assets.

Key coverage areas include senior housing market trends, medical office lease agreements, and research facility developments. All content is verified through primary sources to ensure accuracy and compliance with financial disclosure standards.

Bookmark this page for streamlined access to Ventas' latest press releases and sector analysis. Regularly updated to reflect new developments impacting this healthcare REIT's market position.

Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) will release its third quarter 2022 earnings on November 3, 2022, after the market closes. A conference call to discuss these results is scheduled for November 4, 2022, at 10:00 a.m. ET. Investors can participate via a dial-in number or through a live webcast available on www.ventasreit.com. Ventas operates over 1,200 properties across the U.S., Canada, and the U.K., focusing on healthcare and real estate sectors driven by the growing aging population.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.86%
Tags
conferences earnings
-
Rhea-AI Summary

Ardent Health Services has appointed Carlene Callis as chief system integration and growth officer and Ben Jacobs as chief strategy and development officer. Callis will enhance care delivery and operational efficiency across the organization. With over 25 years in healthcare, she previously served at HCA. Jacobs, with nearly two decades of experience, will focus on strategic planning and expansion into new markets. Both leaders aim to strengthen Ardent’s mission of improving community healthcare access.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.42%
Tags
management
-
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) announced its participation in investor meetings at the Mizuho Healthcare REIT Conference on October 4, 2022. Written materials for the event will be available on the Company's website around the same date, and these will be archived for a limited time.

Ventas operates over 1,200 properties across the United States, Canada, and the United Kingdom, focusing on healthcare and real estate. The company’s strategy emphasizes diversification and financial strength, aimed at unlocking value in senior living and healthcare real estate.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.59%
Tags
conferences
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) has declared a quarterly dividend of $0.45 per share, payable on October 14, 2022, to stockholders recorded by the close of business on October 3, 2022.

As a leading real estate investment trust, Ventas operates in healthcare and real estate sectors with a portfolio of over 1,200 properties across the United States, Canada, and the United Kingdom. The company leverages its capital to enhance senior living, life science, and healthcare real estate.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.39%
Tags
dividends earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.91%
Tags
none
-
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) announced that CEO Debra A. Cafaro will receive the Women Corporate Directors (WCD) 2022 Visionary Award for Strategic Leadership. This award honors women leaders who promote diversity and long-term growth. Under Cafaro's leadership since 1999, Ventas's market capitalization surged from $200 million to $25 billion by 2022. The company is recognized for its commitment to environmental, social, and governance standards and for fostering a diverse workforce.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.79%
Tags
none
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) has appointed Sumit Roy, President & CEO of Realty Income Corporation, to its Board of Directors effective October 1, 2022. Roy brings extensive experience in the REIT sector, having successfully led Realty Income’s growth and strategic initiatives. Concurrently, Robert D. Reed will retire from the Board after serving since 2008, effective at the 2023 Annual Meeting. Ventas's Board now comprises 12 directors, with 11 independent members, maintaining a diverse representation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.79%
Tags
management
-
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) announced that its management will participate in investor meetings at the BofA Securities 2022 Global Real Estate Conference on September 13, 2022, at 1:25 p.m. Eastern Time. The presentation will be available via webcast on the Company’s website. Accompanying materials will be accessible on or about September 12, 2022. Ventas, a leader in healthcare and real estate, manages a portfolio of over 1,200 properties across the U.S., Canada, and the U.K., focusing on senior living and healthcare facilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.25%
Tags
conferences
-
Rhea-AI Summary

Pure Health, a subsidiary of Alpha Dhabi Holding, has announced a $500 million minority equity investment in Ardent Health Services, a leading U.S. healthcare provider. This investment aims to enhance Pure Health's presence in the U.S. healthcare market. Ardent, ranked as the fourth largest private hospital operator in the U.S., operates 30 hospitals and 200+ care sites across six states. The investment is pending customary closing conditions and necessary U.S. regulatory approvals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.5%
Tags
none
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) announced its Q2 2022 results, reporting a per-share Attributable Net Income (Loss) of ($0.11) and Normalized Funds from Operations (FFO) of $0.72. The company achieved a 3.5% year-over-year growth in same-store cash Net Operating Income (NOI), with the Senior Housing Operating Portfolio (SHOP) segment growing nearly 9%. The company anticipates continued growth in Q3 2022, bolstered by HHS grants and strong demand in its SHOP segment. Ventas also reported $1.3 billion in investments year-to-date, with notable projects underway in partnership with major research institutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.77%
Tags

FAQ

What is the current stock price of Ventas (VTR)?

The current stock price of Ventas (VTR) is $65.8 as of July 18, 2025.

What is the market cap of Ventas (VTR)?

The market cap of Ventas (VTR) is approximately 28.6B.
Ventas

NYSE:VTR

VTR Rankings

VTR Stock Data

28.56B
448.76M
0.57%
99.91%
2.85%
REIT - Healthcare Facilities
Real Estate Investment Trusts
Link
United States
CHICAGO